Madhuri Roy

Cooley LLP - UNITED STATES


Madhuri Roy 's competencies

Practice Area Jurisdiction Rank Agg. Deals Value Clients Dimension N. of Transactions Last Quarter
IP&ITUNITED STATES12555001501
Practice Area Jurisdiction Rank Agg. Deals Value Clients Dimension N. of Transactions Last Quarter

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

FusionCharts will load here.

Technical skills

FusionCharts will load here.

Efficiency

FusionCharts will load here.


Effectiveness

FusionCharts will load here.



Perceived Added Value

FusionCharts will load here.

Ranking 2022: Madhuri Roy - Cooley LLP

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
IP&IT55001501
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2021: Madhuri Roy - Cooley LLP

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: Madhuri Roy - Cooley LLP

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
IP&IT35035001
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the Madhuri  Roy 's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
FusionCharts XT will load here!

Team

The chart shows a balanced list of counselor working with Madhuri  Roy - based on PBV Monitor's analyzed transactions during last Twelve Mounths
FusionCharts XT will load here!

Co-Counsel

The Chart shows a balanced list of Madhuri  Roy 's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths
FusionCharts XT will load here!

Counterparts

The Chart shows a balanced list of Madhuri  Roy 's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths
FusionCharts XT will load here!

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment


FusionCharts will load here.

Recent experiences

Neumora Therapeutics' $250.1 Million Initial Public Offering9/26/2023
Eli Lilly's $1.925 Billion Acquisition of Versanis Bio7/21/2023
Apogee Therapeutics' Initial Public Offering7/18/2023